Educational Areas/Call for Grants

Areas of Educational Interest Available Funding Call for Grants
Cardiovascular
Acute Coronary Syndrome
High Risk Prior Myocardial Infarction
Hypertriglyceridemia
Heart Failure – SGLT2 Inhibition
Endocrinology
Type 1 Diabetes
Type 2 Diabetes
Type 2 Diabetes – Heart Failure
Type 2 Diabetes – Chronic Kidney Disease
MedImmune
Research & Development Support
Nephrology
Chronic Kidney Disease - Anemia
Chronic Kidney Disease – SGLT2 Inhibition
Hyperkalemia
Oncology
Advanced Breast Cancer
BRCA
Non-BRCA
DNA Damage Response
PARP Inhibition
HER2+
Metastatic HR+
Gastric Cancer
Gastric Cancer - HER2+
Hematology
CLL (Chronic Lymphocytic Leukemia)
MCL (Mantle Cell Lymphoma)
HCL (Hairy Cell Leukemia)
WM (Waldenstrom Macroglobulinemia)
Immuno-Oncology
Bladder
imAE Management
Extensive-Stage SCLC
Non-Metastatic NSCLC
HCC (Hepatocellular Carcinoma)
IO Diagnostics - Multidisciplinary Team
IO Lung Diagnostics - Staging
Neurofibromatosis
Neurofibromatosis Type 1
Plexiform Neurofibromas
Non-Small Cell Lung Cancer
EGFR Diagnostics & Plasma Testing
EGFRm+ NSCLC
Ovarian Cancer
BRCA
Non-BRCA
PARP Inhibition
DNA Damage Response
Pancreatic Cancer
BRCA
DNA Damage Response
PARP Inhibition
Prostate Cancer (mCRPC)
DNA Damage Response
Homologus Recombination Repair
PARP Inhibition
Respiratory
COPD (Limited US Budget)
Chronic Cough (EX-US only)
Asthma (EX-US only)
Severe Asthma (Limited US Budget)
Rheumatology/Immunology/Autoimmune Rheumatology/
Immunology/
Autoimmune
Systemic Lupus Erythematosus
R & D Discovery
Scientific or educational activities designed to educate research scientists, principal researchers, drug development professionals, academics, pre-doctoral students, doctoral students and fellows. These programs must be educational and non-promotional in nature and planned, designed and implemented in accordance with the U.S. Food and Drug Administration's Guidance on Industry-Supported Scientific and Educational Activities.